Amit Kumar Gupta

Lupin Limited announced US FDA approval and launch of generic Dapagliflozin Tablets, 5 mg and 10 mg, as bioequivalent to AstraZeneca's Farxiga®. The product launch expands Lupin's US portfolio in the